The relation between thyroid function and anemia: a pooled analysis of individual participant data.

Wopereis, Daisy M; Du Puy, Robert S; van Heemst, Diana; Walsh, John P; Bremner, Alexandra; Bakker, Stephan J L; Bauer, Douglas C; Cappola, Anne R; Ceresini, Graziano; Degryse, Jean; Dullaart, Robin P F; Feller, Martin; Ferrucci, Luigi; Floriani, Carmen; Franco, Oscar H; Iacoviello, Massimo; Iervasi, Georgio; Imaizumi, Misa; Jukema, J Wouter; Khaw, Kay-Tee; ... (2018). The relation between thyroid function and anemia: a pooled analysis of individual participant data. Journal of clinical endocrinology and metabolism, 103(10), pp. 3658-3667. Endocrine Society 10.1210/jc.2018-00481

Preview	Text Wopereis JClinEndocrinolMetab 2018_accepted.pdf - Accepted Version Available under License Publisher holds Copyright. Download (450kB) | Preview
Preview	Text Wopereis JClinEndocrinolMetab 2018.pdf - Published Version Available under License Publisher holds Copyright. Download (700kB) | Preview

Context

Anemia and thyroid dysfunction often co-occur and both increase with age. Human data on the relationship between thyroid disease and anemia are scarce.

Objective

To investigate the cross-sectional and longitudinal associations between clinical thyroid status and anemia.

Design

Individual participant data meta-analysis.

Setting

Sixteen cohorts participating in the Thyroid Studies Collaboration (n=42 162).

Main outcome measures

Primary outcome measure was anemia (hemoglobin <130 g/L in men and <120 g/L in women).

Results

Cross-sectionally, participants with abnormal thyroid status had an increased risk of having anemia compared with euthyroid participants (overt hypothyroidism, pooled odds ratio 1.84 [95% CI: 1.35-2.50], subclinical hypothyroidism 1.21 [1.02-1.43], subclinical hyperthyroidism 1.27 [1.03-1.57], overt hyperthyroidism 1.69 [1.00-2.87]). Hemoglobin levels were lower in all groups compared to participants with euthyroidism. In the longitudinal analyses (n=25,466 from 14 cohorts), the pooled hazard ratio for the risk of development of anemia was 1.38 [95% CI: 0.86-2.20] for overt hypothyroidism, 1.18 [1.00-1.38] for subclinical hypothyroidism, 1.15 [0.94-1.42] for subclinical hyperthyroidism and 1.47 [0.91-2.38] for overt hyperthyroidism. Sensitivity analyses excluding thyroid medication or high levels of C-reactive protein yielded similar results. No differences in mean annual change in hemoglobin levels were observed between the thyroid hormone status groups.

Conclusion

Higher odds of having anemia were observed in both participants with hypothyroid function and hyperthyroid function. In addition, reduced thyroid function at baseline showed a trend of increased risk of developing anemia during follow-up. It remains to be assessed in a randomized controlled trial whether treatment is effective in reducing anemia.

Interest & Impact

Downloads

299 since deposited on 18 Sep 2018
31 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item